Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 45.

Oesch, F; Dietrich, C; Naegeli, H; Schwarz, M; van der Horst, G; Zanger, U; Oesch, B; Weiss, C (2008). New aspects on mechanisms of chemical carcinogenesis: emphasis on species and gender/sex differences and developmental/aging determinants. Archives of Toxicology, 82(11):875-880.

Oesch-Bartlomowicz, B; Huelster, A; Wiss, O; Antoniou-Lipfert, P; Dietrich, C; Arand, M; Weiss, C; Bockamp, E; Oesch, F (2005). Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 102(26):9218-9223.

Ringhoffer, M; Schmitt, M; Karbach, J; Jäger, E; Oesch, F; Arand, M (2001). Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction. International Journal of Oncology, 19(5):983-989.

Härtter, S; Wang, X; Weigmann, H; Friedberg, T; Arand, M; Oesch, F; Hiemke, C (2001). Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. Journal of Clinical Psychopharmacology, 21(2):167-174.

Zou, J; Hallberg, B M; Bergfors, T; Oesch, F; Arand, M; Mowbray, S L; Jones, T A (2000). Structure of Aspergillus niger epoxide hydrolase at 1.8 A resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolases. Structure, 8(2):111-22.

Oesch, F; Herrero, M E; Hengstler, J G; Lohmann, M; Arand, M (2000). Metabolic detoxification: implications for thresholds. Toxicologic pathology, 28(3):382-387.

Arand, M; Hemmer, H; Dürk, H; Baratti, J; Archelas, A; Furstoss, R; Oesch, F (1999). Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase. Biochemical Journal, 344 Pt 1:273-280.

Hengstler, J G; Lange, J; Kett, A; Dornhöfer, N; Meinert, R; Arand, M; Knapstein, P G; Becker, R; Oesch, F; Tanner, B (1999). Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. Cancer Research, 59(13):3206-3214.

Mullen, R T; Trelease, R N; Duerk, H; Arand, M; Hammock, B D; Oesch, F; Grant, D F (1999). Differential subcellular localization of endogenous and transfected soluble epoxide hydrolase in mammalian cells: evidence for isozyme variants. FEBS letters, 445(2-3):301-305.

Arand, M; Müller, F; Mecky, A; Hinz, W; Urban, P; Pompon, D; Kellner, R; Oesch, F (1999). Catalytic triad of microsomal epoxide hydrolase: replacement of Glu404 with Asp leads to a strongly increased turnover rate. Biochemical Journal, 337 ( Pt:37-43.

Hengstler, J G; Kett, A; Arand, M; Oesch-Bartlomowicz, B; Oesch, F; Pilch, H; Tanner, B (1998). Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Letters, 130(1-2):43-48.

Tanner, B; Hengstler, J G; Luch, A; Meinert, R; Kreutz, E; Arand, M; Wilkens, C; Hofmann, M; Oesch, F; Knapstein, P G; Becker, R (1998). C-myc mRNA expression in epithelial ovarian carcinomas in relation to estrogen receptor status, metastatic spread, survival time, FIGO stage, and histologic grade and type. International Journal of Gynecological Pathology, 17(1):66-74.

Müller, F; Arand, M; Frank, H; Seidel, A; Hinz, W; Winkler, L; Hänel, K; Blée, E; Beetham, J K; Hammock, B D; Oesch, F (1997). Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates. European Journal of Biochemistry, 245(2):490-496.

Jäger, E; Ringhoffer, M; Altmannsberger, M; Arand, M; Karbach, J; Jäger, D; Oesch, F; Knuth, A (1997). Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. International Journal of Cancer, 71(2):142-147.

Herrero, M E; Arand, M; Hengstler, J G; Oesch, F (1997). Recombinant expression of human microsomal epoxide hydrolase protects V79 Chinese hamster cells from styrene oxide- but not from ethylene oxide-induced DNA strand breaks. Environmental and Molecular Mutagenesis, 30(4):429-439.

Jäger, E; Ringhoffer, M; Arand, M; Karbach, J; Jäger, D; Ilsemann, C; Hagedorn, M; Oesch, F; Knuth, A (1996). Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma research, 6(6):419-425.

Friedberg, T; Holler, R; Löllmann, B; Arand, M; Oesch, F (1996). The catalytic activity of the endoplasmic reticulum-resident protein microsomal epoxide hydrolase towards carcinogens is retained on inversion of its membrane topology. Biochemical Journal, 319:131-136.

Jäger, E; Ringhoffer, M; Dienes, H P; Arand, M; Karbach, J; Jäger, D; Ilsemann, C; Hagedorn, M; Oesch, F; Knuth, A (1996). Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. International Journal of Cancer, 67(1):54-62.

Oesch, F; Arand, M; Benedetti, M S; Castelli, M G; Dostert, P (1996). Inducing properties of rifampicin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver. Journal of Antimicrobial Chemotherapy, 37(6):1111-1119.

Jäger, E; Ringhoffer, M; Karbach, J; Arand, M; Oesch, F; Knuth, A (1996). Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. International Journal of Cancer, 66(4):470-476.

Arand, M; Mühlbauer, R; Hengstler, J; Jäger, E; Fuchs, J; Winkler, L; Oesch, F (1996). A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Analytical Biochemistry, 236(1):184-186.

Arand, M; Wagner, H; Oesch, F (1996). Asp333, Asp495, and His523 form the catalytic triad of rat soluble epoxide hydrolase. Journal of Biological Chemistry, 271(8):4223-4229.

Fändrich, F; Degiuli, B; Vogel-Bindel, U; Arand, M; Oesch, F (1995). Induction of rat liver microsomal epoxide hydrolase by its endogenous substrate 16 alpha, 17 alpha-epoxyestra-1,3,5-trien-3-ol. Xenobiotica; the fate of foreign compounds in biological systems, 25(3):239-244.

Beetham, J K; Grant, D; Arand, M; Garbarino, J; Kiyosue, T; Pinot, F; Oesch, F; Belknap, W R; Shinozaki, K; Hammock, B D (1995). Gene evolution of epoxide hydrolases and recommended nomenclature. DNA and cell biology, 14(1):61-71.

Härtter, S; Arand, M; Oesch, F; Hiemke, C (1995). Non-competitive inhibition of clomipramine N-demethylation by fluvoxamine. Psychopharmacology, 117(2):149-153.

Diener, B; Abdel-Latif, H; Arand, M; Oesch, F (1995). Xenobiotic metabolizing enzyme activities and viability are well preserved in EDTA-isolated rat liver parenchymal cells after cryopreservation. Toxicology and applied pharmacology, 130(1):149-153.

Oesch, F; Hengstler, J G; Arand, M; Fuchs, J (1995). Detection of primary DNA damage: applicability to biomonitoring of genotoxic occupational exposure and in clinical therapy. Pharmacogenetics, 5 Spec N:S118-S122.

Diener, B; Traiser, M; Arand, M; Leissner, J; Witsch, U; Hohenfellner, R; Fändrich, F; Vogel, I; Utesch, D; Oesch, F (1994). Xenobiotic metabolizing enzyme activities in isolated and cryopreserved human liver parenchymal cells. Toxicology in Vitro, 8(6):1161-1166.

Strolin Benedetti, M S; Marrari, P; Colombo, M; Castelli, M G; Arand, M; Oesch, F; Dostert, P (1994). The anticonvulsant FCE 26743 is a selective and short-acting MAO-B inhibitor devoid of inducing properties towards cytochrome P450-dependent testosterone hydroxylation in mice and rats. Journal of Pharmacy and Pharmacology, 46(10):814-819.

Hammock, B D; Pinot, F; Beetham, J K; Grant, D F; Arand, M E; Oesch, F (1994). Isolation of a putative hydroxyacyl enzyme intermediate of an epoxide hydrolase. Biochemical and Biophysical Research Communications, 198(3):850-856.

Arand, M; Grant, D F; Beetham, J K; Friedberg, T; Oesch, F; Hammock, B D (1994). Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins. Implication for the potential catalytic mechanism of enzymatic epoxide hydrolysis. FEBS letters, 338(3):251-256.

Knehr, M; Thomas, H; Arand, M; Gebel, T; Zeller, H D; Oesch, F (1993). Isolation and characterization of a cDNA encoding rat liver cytosolic epoxide hydrolase and its functional expression in Escherichia coli. Journal of Biological Chemistry, 268(23):17623-17627.

Utesch, D; Arand, M; Thomas, H; Petzinger, E; Oesch, F (1992). Xenobiotic-metabolizing enzyme activities in hybrid cell lines established by fusion of primary rat liver parenchymal cells with hepatoma cells. Xenobiotica; the fate of foreign compounds in biological systems, 22(12):1451-1457.

Arand, M; Friedberg, T; Oesch, F (1992). Colorimetric quantitation of trace amounts of sodium lauryl sulfate in the presence of nucleic acids and proteins. Analytical Biochemistry, 207(1):73-75.

Oesch, F; Wagner, H; Platt, K L; Arand, M (1992). Improved sample preparation for the testosterone hydroxylation assay using disposable extraction columns. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 582(1-2):232-235.

Friedberg, T; Grassow, M A; Bartlomowicz-Oesch, B; Siegert, P; Arand, M; Adesnik, M; Oesch, F (1992). Sequence of a novel cytochrome CYP2B cDNA coding for a protein which is expressed in a sebaceous gland, but not in the liver. Biochemical Journal, 287:775-783.

Gebel, T; Arand, M; Oesch, F (1992). Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver. FEBS letters, 309(1):37-40.

Oesch, F; Arand, M; Coughtrie, M W; Burchell, B; Steinberg, P (1992). The distribution of UDP-glucuronosyltransferases in rat liver parenchymal and nonparenchymal cells. Biochemical Pharmacology, 43(4):731-737.

Arand, M; Knehr, M; Thomas, H; Zeller, H D; Oesch, F (1991). An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase. FEBS letters, 294(1-2):19-22.

Arand, M; Coughtrie, M W; Burchell, B; Oesch, F; Robertson, L W (1991). Selective induction of bilirubin UDP-glucuronosyl-transferase by perfluorodecanoic acid. Chemico-biological interactions, 77(1):97-105.

Oesch, F; Arand, M (1989). Molecular aspects of carcinogenesis. Part B. Journal of Cancer Research and Clinical Oncology, 115(6):606-607.

Arand, M; Robertson, L W; Oesch, F (1987). A fluorometric assay for quantitating phenol sulfotransferase activities in homogenates of cells and tissues. Analytical Biochemistry, 163(2):546-551.

Azais, V; Arand, M; Rauch, P; Schramm, H; Bellenand, P; Narbonne, J F; Oesch, F; Pascal, G; Robertson, L W (1987). A time-course investigation of vitamin A levels and drug metabolizing enzyme activities in rats following a single treatment with prototypic polychlorinated biphenyls and DDT. Toxicology, 44(3):341-354.

Glatt, H R; Robertson, L W; Arand, M; Rauch, P; Schramm, H; Setiabudi, F; Pöchlauer, P; Müller, E P; Oesch, F (1986). cis- and trans-1,2-diphenylaziridines: induction of xenobiotic-metabolizing enzymes in rat liver and mutagenicity in Salmonella typhimurium. Archives of toxicology, 59(4):242-248.

Azais, V; Pascal, G; Arand, M; Oesch, F; Robertson, L W (1986). Effects of congeneric polychlorinated biphenyls on liver and kidney retinoid levels. Chemosphere, 15(9-12):1905-1908.

This list was generated on Wed Sep 26 07:19:56 2018 CEST.